Molina, Kyle C.
Miller, Matthew A.
Mueller, Scott W.
Van Matre, Edward T.
Krsak, Martin
Kiser, Tyree H. http://orcid.org/0000-0001-7415-3999
Article History
Accepted: 2 November 2021
First Online: 21 December 2021
Declarations
:
: Tyree H. Kiser reports previous investigator-initiated dalbavancin research funding paid to his institution from Allergan Pharmaceuticals. Matthew A. Miller reports participation in the speaker’s bureau for Allergan Pharmaceuticals. Kyle C. Molina, Scott W. Mueller, Edward Van Matre, and Martin Krsak have no disclosures to declare.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.